×
HEURISTIK

Heuristik

Invest with tax advantages: deduct up to 50% on your next income tax return

Xavier Castells
Notable investor Xavier Castells
Ticket IR €150,000
  • Invested €382,028
  • Min. goal €400,000
  • Max. goal €600,000
  • 63.67% completed
  • 6 days left
  • Invested €382,028
  • Min. goal €400,000
  • Max. goal €600,000
  • 63.67% completed
  • 42 Investors
  • 6
Invest in less than 5 min.

Understanding the investment opportunity

Heuristik is a software solution for patient identification and management that combines fingerprints with artificial intelligence.

Founded in 2019, Heuristik is a Spanish startup pioneering in the field of patient identification and management through biometric technology. Its innovative software, which combines fingerprints with artificial intelligence to identify fingerprints in adverse situations (dirty, wet, or blood-stained), has revolutionized the way medical centers identify and manage their patients, offering an efficient and secure solution to ensure accuracy in the healthcare process.

The idea behind Heuristik arose from a personal incident that deeply affected CEO and founder, Antxon Caballero. After his grandfather experienced a misidentification, receiving the wrong medication due to being confused with another patient, Antxon set out to find a solution to prevent other patients from facing similar situations.



Heuristik's technology not only offers secure and reliable identification but also simplifies administrative processes in healthcare environments, reducing errors and improving staff efficiency. Additionally, its focus on data security ensures compliance with privacy and data protection regulations (GDPR), providing peace of mind to both patients and healthcare providers.

Since its launch, Heuristik has been recognized for its impact on the healthcare industry, winning awards for its innovation and contribution to improving the quality of patient care. With a clear vision and unwavering commitment to excellence, Heuristik continues to lead the way toward a future where technology and healthcare come together to provide safer and more efficient care for all.

INVESTMENT STAGE

PRE_SEED

MARKET

  • digital health
  • artificial-intelligence
  • biometrics

OFFICIAL WEBPAGE

VIDEOS

Heuristik Team

Antxon Caballero CEO
Antxon Caballero
CEO

Ruben Lopez CTO
Ruben Lopez
CTO

Tatiana Yglesias

Tatiana Yglesias

CSO

Jose Carlos Aradillas

Jose Carlos Aradillas

Head of AI

Jonathan Sanz

Jonathan Sanz

Sr. Front end

Carlos Crisostomo

Carlos Crisostomo

Sr. DevOps

Jorge Duran

Jorge Duran

Sr. Rust developer

Gerard Espuga

Gerard Espuga

DPO

Thomas Carson

Thomas Carson

Director de Operaciones

Current investors
Jose Ignacio Solaeche

Jose Ignacio Solaeche

BUSINESSANGEL

Xavier Castells

Xavier Castells

BUSINESSANGEL

Accelerators
Acex Healthcare

Acex Healthcare

ACCELERATOR

EIT Health

EIT Health

ACCELERATOR

Health Venture Lab (GE Healthcare)

Health Venture Lab (GE Healthcare)

ACCELERATOR

Idea2 MIT

Idea2 MIT

ACCELERATOR

MassChallenge

MassChallenge

ACCELERATOR

Microsoft Founders Hub

Microsoft Founders Hub

ACCELERATOR

Nvidia Inception

Nvidia Inception

ACCELERATOR

The Hill Oxford

The Hill Oxford

ACCELERATOR

Reasons to invest View more data

VALIDATED TECHNOLOGY: Heuristik’s solution has been implemented and validated in 4 healthcare entities at the national level.




TRACTION:
 Heuristik has two signed contracts (Portugal and Italy) and 15 letters of interest from hospitals in 7 European countries (Spain, Portugal, Poland, Italy, Germany, Croatia, and Romania) plus Israel and the United States.



POTENTIAL MARKET: The healthcare biometrics market is valued at $81B, growing at a 19% CAGR.

PROPRIETARY TECHNOLOGY: Heuristik has developed 100% of its technology.

HARDWARE-AGNOSTIC: Heuristik’s software solution works with any fingerprint hardware on the market.

EXPERIENCED FOUNDING TEAM: Heuristik boasts a senior C-level team with members like Antxon, who had an exit with his previous company, Tatiana with over 20 years of experience working at Novartis Boston, and Ruben, a CTO with more than 15 years of experience managing tech teams. There are several notable team members: Jose Carlos, Ph.D. in Artificial Intelligence; Thomas, who was the fifth employee at a medical device startup in Switzerland and helped it grow to 70 employees; and Carlos Crisóstomo, with over 20 years of experience developing infrastructure as a DevOps engineer.

ADDRESSING A REAL PROBLEM: Heuristik was born 5 years ago when a nurse made an identification error involving the grandfather of Heuristik's CEO, Antxon Caballero. The WHO reports that the average rate of identification errors in hospitals is currently 10%, in Europe, there are more than 500M identification errors annually, with costs exceeding €200B.

INVESTORS, ACCELERATORS, AND MULTIPLE AWARDS BACK THE PROJECT:


Awards

  • National award for the most impactful company by Fundación Repsol
  • Vithas Acex Healthcare Award
  • Madrid Impacta Award for the social company with the greatest growth potential and international projection
  • Caelestinus Award for the company with the highest number of pilot projects
  • Finalist of Santander X Global Healthcare Innovation Challenge (out of over 700 companies worldwide)
  • Finalist of the European Health Tech Challengers

Accelerators

  • MIT and MassChallenge (Boston)
  • Nvidia and Microsoft (United States)
  • GE Healthcare (Budapest)
  • The Hill (Oxford)
  • Acex Healthcare (Granada)
  • EIT Health (Patient Innovation Bootcamp, Bridgehead, and EIC accelerator)

And in 2025, in collaboration with Hospital Da Luz in Portugal, the first results will be obtained for the publication of the paper, demonstrating that Heuristik’s solution is capable of identifying patients with 100% effectiveness and in a cost-efficient manner.

      Who is the reference investor?

      Xavier Castells

      Xavier Castells

      BUSINESSANGEL

      Ticket IR €150,000
      About Xavier Castells
      Xavier es un emprendedor en serie del mundo de las ciencias de la vida. En su experiencia como director y CFO de varias Startups ha colaborado activamente en la incorporación de dos empresas de ciencias de la vida a la bolsa (Inkemia y Vytrus Biotech) y está a punto de sacar la tercera. También ha colaborado activamente para Venture Funds del sector.
      • Investing in startups:> 10 years
      • Invested Euros:1,5 M €
      • Investments:11
      • Exits:2
      Why do I invest in Heuristik?

      I have over 12 years of experience in the health sector, and I have seen that in recent years digital health has been experiencing significant growth. The digitization of hospitals and technologies that streamline processes are becoming increasingly important every day.

      When I met Antxon, I was impressed by the passion he inspires and his ability to set aside his EGO and listen. I believe that the Heuristik solution is well-positioned for exponential growth once they conclude the phase they are currently immersed in.

      Heuristik is a solution that not only helps reduce identification errors but also helps reduce hospital costs. For this reason, I believe they have a winning product.

      It has also invested in...
      Live
      Chat

      You need to be registered to view the content

      This content is confidential and you must be registered with Startupxplore in order to access it.

      Register me

      Opportunity analysis Last update Jun 27, 2025 2:05:54 PM

      You need to be registered to view the content

      This content is confidential and you must be registered with Startupxplore in order to access it.

      Register me

      Investor questions

      The regulations governing Startupxplore's activity require that no investor is in possession of more information than the rest. Therefore, this section will provide answers to any questions asked by an investor about the opportunity.

      If you have any doubts or questions about the startup, the process or any other aspect please write to us at coinversion@startupxplore.com

      You need to be registered to view the content

      This content is confidential and you must be registered with Startupxplore in order to access it.

      Register me

      Documentation

      You need to be registered to view the content

      This content is confidential and you must be registered with Startupxplore in order to access it.

      Register me
      Important

      Startup investments have associated risks, including: Liquidity Risk, Information Risk, Risk of loosing partially or totally the investment capital, fast changing operation environment, regulatory and legal risks, minority investment risks, no capacity of influence on the company management. Due to the high uncertainty associated to this type of investment, you should contemplate investing only if you fully understand the risks and always as part of a diversified investment portfolio.

      Click here to read the “basic information for the customer” before investing.

      Startupxplore works with investors of recognised prestige and applies a very strict policy to manage conflicting interests. In this way we aim to ensure that all the published projects have a solid base, but in no way, Startupxplore can be responsible for the investment decisions taken by its platform members, as well as for the opinions and comments stated by companies might published in the platform.

      Startupxplore works with prestigious investors and applies a strict policy for the management of conflicts of interest, in this way we try to ensure that the published projects have a solid basis but, in no way, Startupxplore may be responsible for the investment decisions that the members of its platform take, as well as for the opinions and comments that the companies publish.

      In accordance with REGULATION (EU) 2020/1503 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL, we inform you that, like all crowdfunding service platforms, Startupxplore complies with the current regulations, particularly with:

      PRE-CONTRACTUAL REFLECTION PERIOD

      There is a pre-contractual reflection period for non-sophisticated investors during which they may revoke their expression of interest in the crowdfunding offer without needing to justify their decision and without incurring a penalty. This reflection period will begin at the moment of the expression of interest by the non-sophisticated investor and will expire at the end of four calendar days. The way to revoke an expression of interest will be via email to ops@startupxplore.com from the same email address used by the non-sophisticated investor to express interest in the crowdfunding offer. Immediately after receiving the investment offer or the expression of interest, Startupxplore will inform the potential non-sophisticated investor, through its crowdfunding platform, that the reflection period has begun.

      LACK OF COVERAGE BY THE DEPOSIT GUARANTEE SCHEME

      Crowdfunding services are not covered by the deposit guarantee scheme established in accordance with Directive 2014/49/EU. Negotiable securities or instruments admitted for crowdfunding acquired through this crowdfunding platform are not covered by the investor compensation scheme established in accordance with Directive 97/9/EC.

      Haz scroll para continuar...